Emerging Research of Rapamycin: A Drug That Could Revolutionize Aging and Extend Lifespan
Hospice News
NOVEMBER 26, 2024
Overland Park, Kansas — Rapamycin, a drug traditionally used to prevent organ rejection after transplants, is increasingly drawing attention in the realm of anti-aging research. Originally developed as an immunosuppressant, the drug’s potential to slow aging and extend lifespan has become the focus of numerous studies in recent years. With mounting evidence suggesting that rapamycin could play a critical role in combating age-related diseases and enhancing longevity, scientists are now exploring
Let's personalize your content